1. Humoral immunity in renal transplantation: clinical significance and therapeutic approach.
- Author
-
Rowshani, Ajda T., Bemelman, Frederieke J., Lardy, Neubury M., and Ten Berge, Ineke J. M.
- Subjects
- *
IMMUNOGLOBULINS , *TRANSPLANTATION of organs, tissues, etc. , *GRAFT rejection , *HLA histocompatibility antigens , *KIDNEY transplantation - Abstract
Donor-specific antibodies (DSA) form a significant barrier in solid organ transplantation of highly pre-sensitized candidates. Although avoiding transplantation over a positive cross-match test can largely prevent the occurrence of hyperacute antibody-mediated rejection, transplantation of highly pre-sensitized candidates is often complicated by the occurrence of acute and chronic antibody-mediated graft rejection leading to diminished graft function and survival. The pre-existent HLA and/or non-HLA-specific antibodies are without any doubt important contributing factors underlying humoral-mediated graft injury. Furthermore, increasing evidence underlines the association of newly formed de novo DSA after transplantation with poor graft function and survival. There is still a need to further develop desensitizing therapies not only to make transplantation of highly pre-sensitized candidates feasible, but also to reduce the new formation of allo-antibodies. Here, we summarize current views on desensitization therapies and the impact of the presence of DSA on the fate of the kidney graft. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF